| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/01/1997 | WO1997015577A1 Reverse-turn mimetics and methods relating thereto |
| 05/01/1997 | WO1997015572A1 Lubeluzole n-oxide |
| 05/01/1997 | WO1997015570A1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015555A2 Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015309A1 Method of inhibiting sleep apnea |
| 05/01/1997 | WO1997015307A1 Eye drops |
| 05/01/1997 | WO1997015302A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | WO1997015301A1 Method of adjusting the circadian rhythm of a mammal |
| 05/01/1997 | WO1997015281A1 Use of at least one beta-adrenergic agonist as a p substance antagonist |
| 05/01/1997 | CA2235854A1 Method of inhibiting sleep apnea |
| 05/01/1997 | CA2235803A1 Method of adjusting the circadian rhythm of a mammal |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235621A1 Imidazole derivatives and their use as nitrogen monoxide synthase inhibitors |
| 05/01/1997 | CA2235614A1 Eye drops |
| 05/01/1997 | CA2235360A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | CA2232336A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | CA2228054A1 Lubeluzole n-oxide |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 05/01/1997 | CA2186412A1 Ethylamino carbazole melatonergic agents |
| 04/30/1997 | DE19541146A1 Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren Imidazole derivatives and their use as nitric oxide synthase inhibitors |
| 04/30/1997 | CN1148854A Tropane-z-aldoxine derivatives and preparation process and use thereof |
| 04/30/1997 | CN1148849A Process for preparing anhydrous and hydrate forms of antihistaminic pipeeridine derivatives, polymorphs and spseudormophs thereof |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/30/1997 | CN1034733C Spiro piperidines and homologs which promote release of growth hormone |
| 04/30/1997 | CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 04/29/1997 | US5625067 Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use |
| 04/29/1997 | US5625061 Graft=glycinamide riboncleotide formyl transferase |
| 04/29/1997 | US5624957 Retinoid active compounds |
| 04/29/1997 | US5624950 Useful in treatment of analgesia, inflammation, asthma, allergies, central nervous system disorders, cardiovascular disorders, immune system disorders, antispasmodic agents, antiemetic agents |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624943 Pyridine compounds which are useful as leukotriene-B4 -antagonists |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 04/29/1997 | US5624931 Pyrazole derivatives |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/29/1997 | US5624670 Use of interleukin-8 for inducing cervical ripening |
| 04/29/1997 | CA2089207C Amphoteric tricyclic compound |
| 04/29/1997 | CA2065501C Preparation process of ginkgolide b from ginkgolide c |
| 04/29/1997 | CA2021546C [r-(r*r*)]1-2-(4-fluorophenyl).beta.-.delta.-dihydroxy-5- (1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]-1h-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/28/1997 | CA2187911A1 Prolongation of organ transplantation using rapamycin loaded donor splenocytes |
| 04/28/1997 | CA2186192A1 Topical composition containing specific flavanones |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014691A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 04/24/1997 | WO1997014684A1 Amino substituted pyrimidines and triazines |
| 04/24/1997 | WO1997014671A1 Cyclopentyl tachykinin receptor antagonists |
| 04/24/1997 | WO1997014437A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | CA2233848A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 04/24/1997 | CA2229710A1 Amino substituted pyrimidines and triazines |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769300A2 Antiemetic composition containing an NK-1 receptor antagonists |
| 04/23/1997 | EP0769293A2 Use of at least a beta-adrenergic agonist as an antagonist of substance P |
| 04/23/1997 | EP0769059A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769006A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/23/1997 | EP0769005A2 Pla 2? inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 04/23/1997 | EP0768891A1 Use of insulin and igf-i |
| 04/23/1997 | EP0768890A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 04/23/1997 | EP0768889A1 Cancer therapy using lymphotoxin |
| 04/23/1997 | EP0768881A2 Anti-hiv triple combination |
| 04/23/1997 | EP0768878A1 Endothelin receptor antagonists |
| 04/23/1997 | EP0768877A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 04/23/1997 | EP0768875A1 Nitric oxide synthase inhibitors for inhibiting the production of airway mucus |
| 04/23/1997 | EP0674484B1 Psyllium drink mix compositions |
| 04/23/1997 | EP0656844B1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 04/23/1997 | EP0651754B1 K-252a DERIVATIVES |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | EP0624196B1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 04/23/1997 | EP0623123B1 Benzopyran and related LTB4-antagonists |
| 04/23/1997 | EP0563249B1 Targeting of therapeutic agents using polysaccharides |
| 04/23/1997 | EP0495049B1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 04/23/1997 | EP0394418B1 Osteogenic factors |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |
| 04/23/1997 | CN1148389A Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 04/23/1997 | CN1148341A Oral liquid alendronate formulations |
| 04/23/1997 | CN1148340A Method for treating 5HT2B receptor related conditions |
| 04/23/1997 | CN1148338A Increasing fetal hemoglobin level using carboxylic esters |
| 04/23/1997 | CN1148337A Compound active at a novel site on receptor-operated calcium channels usefull for treatment of neurological disorders and diseases |
| 04/23/1997 | CN1147941A Medicine for curing deficiency of liver and kidney |
| 04/23/1997 | CN1147902A Zilpaterol hydrochloride in specific crystallized form, its prepn. process and intermediate products used |
| 04/22/1997 | US5622989 Amino-benzofuryl-and thienyl-derivatives |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622985 Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
| 04/22/1997 | US5622984 Amidinophenol derivatives |
| 04/22/1997 | US5622982 Enzyme inhibitors; antiinflammatory agents |
| 04/22/1997 | US5622976 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 04/22/1997 | US5622975 Prophylaxis or treatment of cardiovascular disorders such as atherosclerosis, restenosis, inflammation, or malignant invasion |
| 04/22/1997 | US5622969 Administering to human or animal suffering from allergic reaction of pulmonary system and other inflammatory disorders |
| 04/22/1997 | US5622963 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |